Clinical Trials Logo

Filter by:
NCT ID: NCT03091842 Withdrawn - Clinical trials for Stage IIIA Breast Cancer

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer

Start date: July 29, 2019
Phase: N/A
Study type: Interventional

This randomized phase II trial studies how well exercise intervention works in targeting adiposity and inflammation with movement to improve prognosis in stage I-III breast cancer survivors. Different types of exercise may reduce inflammation in fat tissue and minimize the risk of cancer recurrence related to being overweight or obese.

NCT ID: NCT03091803 Withdrawn - Clinical trials for Intracranial Neoplasm

QSM and Regional DCE MRI Permeability Using GOCART Technique

Start date: April 4, 2017
Phase:
Study type: Observational

This randomized pilot clinical trial studies quantitative susceptibility mapping (QSM) and regional dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) permeability using golden-angle cartesian randomized time-resolved (GOCART) technique in evaluating regional gadolinium retention in the brain in patients with intracranial neoplasm receiving gadobenate dimeglumine or gadoterate meglumine. MRI diagnostic techniques such as, QSM and DCE MRI, may help to gather information regarding brain changes associated with gadolinium deposits during 8 to 18 months after administration of gadobenate dimeglumine or gadoterate meglumine.

NCT ID: NCT03091205 Withdrawn - Atrial Fibrillation Clinical Trials

Proper Extent of Maze Intercaval Lesion

Maze
Start date: April 15, 2018
Phase:
Study type: Observational

It's hypothesized that a mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue can be measured to better inform surgeons performing the Cox-Maze procedure. A patient scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible could be entered into the study if they meet the inclusion/exclusion requirements.

NCT ID: NCT03090919 Withdrawn - Sepsis Clinical Trials

The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis

INFUSE
Start date: January 3, 2017
Phase: N/A
Study type: Interventional

Sepsis is life-threatening and dysregulated response to infection that results in endothelial activation and dysfunction that leads to systemic microvascular leak and multiple-organ failure. This study will identify patients that have sepsis with thrombocytopenia and randomize them to receive a unit of platelets or an equivalent volume of saline.

NCT ID: NCT03089476 Withdrawn - Atopic Dermatitis Clinical Trials

Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy

Start date: September 30, 2017
Phase: N/A
Study type: Interventional

It is hypothesized that food allergy is preceded by atopic dermatitis (AD), due to a disruption of skin barrier which can predispose one to food sensitization through the skin. The central hypothesis is that increased transepidermal water loss (TEWL) assessment and skin tape strip analysis (STS) of lipid and filaggrin breakdown products will be predictive markers for the development of AD. Additionally, the associated changes in TEWL and STS will further improve the identification of infants at risk of early food sensitization, compared to family history alone.

NCT ID: NCT03087968 Withdrawn - Clinical trials for Severe Alcoholic Hepatitis

Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124

Start date: July 31, 2016
Phase: Early Phase 1
Study type: Interventional

This clinical investigation is a substudy within GS-US-416-2124, IND 129570, which is A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination with Prednisolone versus Prednisolone Alone in Subjects with Severe Alcoholic Hepatitis. The use of the HepQuant SHUNT test is to assess liver disease severity before, during, and after treatment with GS-4997 or placebo, to assess liver disease severity.

NCT ID: NCT03087578 Withdrawn - Overactive Bladder Clinical Trials

Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

This study compares electroacupuncture to mirabegron for treatment of overactive bladder (OAB) symptoms in women who have failed treatment with anticholingeric therapy.

NCT ID: NCT03087305 Withdrawn - Lung Cancer Clinical Trials

Incidence of SCLN Metastasis in Patients Referred for EBUS-TBNA

Start date: May 1, 2017
Phase: N/A
Study type: Observational

Evaluation of the anatomic extent of a primary lung cancer and presence of metastasis are essential for selection of an appropriate management strategy. Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) is a reliable and established technique to evaluate involvement of mediastinal lymph nodes (LN); however, it is an invasive procedure and may not be tolerated in patients with severe underlying lung disease. One exception is the superficially located supraclavicular lymph nodes (SCLN), which can easily be biopsied with percutaneous US-guided-fine needle aspiration (US-FNA). Traditionally, this nodal group is evaluated by palpation; however, literature suggests that palpation itself fails to capture 66% of proven disease by cytology, which challenges the acceptance that non-palpable nodes are indicative of absent disease. Since all palpable SCLN are biopsied to rule out metastasis, we may potentially up-stage more patients using ultrasound evaluation for non-palpable nodes; and offer more appropriate management. Currently, the incidence for non-palpable SCLN metastasis has not been defined in this patient population presenting for EBUS-TBNA. The primary objective is to determine the incidence of supraclavicular lymph node metastasis by ultrasound evaluation in patients referred for EBUS-TBNA.

NCT ID: NCT03086252 Withdrawn - Leukemia Clinical Trials

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Start date: July 24, 2017
Phase: N/A
Study type: Interventional

This pilot study evaluates safety of administration of red blood cell transfusions requested by patients based on their symptoms instead of levels of hemoglobin for the treatment of chronic anemia in patients with blood disorders.

NCT ID: NCT03084263 Withdrawn - Ankle Fractures Clinical Trials

Arthroscopic Assisted Open Reduction Internal Fixation Versus Open Reduction Internal Fixation in Ankle Fractures

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The objective of this study is to compare the functional outcomes of patients with ankle fractures treated by Arthroscopic assisted Open Reduction Internal Fixation (AORIF) versus Open Reduction Internal Fixation (ORIF).